Human Transforming growth factor beta receptor type 3 (TGFBR3) ELISA Kit (HUEB2057)
- SKU:
- HUEB2057
- Product Type:
- ELISA Kit
- Size:
- 96 Assays
- Uniprot:
- Q03167
- Range:
- 0.156-10 ng/mL
- ELISA Type:
- Sandwich
- Synonyms:
- betaglycan, BGCAN, TGF beta receptor type 3, TGF beta receptor type III, TGF-beta Receptor III, TGFBR3, TGFR 3, TGFbeta RIII
- Reactivity:
- Human
Description
Human Transforming growth factor beta receptor type 3 (TGFBR3) ELISA Kit
The Human Transforming Growth Factor Beta Receptor Type 3 (TGFBR3) ELISA Kit is specifically designed for precise and accurate detection of TGFBR3 levels in human serum, plasma, and cell culture supernatants. This advanced kit offers unparalleled sensitivity and specificity, ensuring consistent and dependable results for a wide range of research applications.TGFBR3 is a key receptor involved in the transforming growth factor beta (TGF-β) signaling pathway, which plays a critical role in cell growth, differentiation, and immune response regulation.
Dysregulation of this pathway has been implicated in various diseases, including cancer, fibrosis, and autoimmune disorders, making TGFBR3 an important biomarker for studying these conditions and developing potential therapeutic interventions.With its superior performance and ease of use, the Human TGFBR3 ELISA Kit is an essential tool for researchers seeking to investigate the role of TGFBR3 in health and disease, paving the way for innovative discoveries and advancements in the field of biomedical research.
Product Name: | Human Transforming growth factor beta receptor type 3 (TGFBR3) ELISA Kit |
SKU: | HUEB2057 |
Size: | 96T |
Target: | Human Transforming growth factor beta receptor type 3 (TGFBR3) |
Synonyms: | Betaglycan, Transforming growth factor beta receptor III, TGF-beta receptor type III, TGF-beta receptor type 3 |
Assay Type: | Sandwich |
Detection Method: | ELISA |
Reactivity: | Human |
Detection Range: | 0.156-10ng/mL |
Sensitivity: | 0.084ng/mL |
Intra CV: | 8.1% | ||||||||||||||||||||
Inter CV: | 10.2% | ||||||||||||||||||||
Linearity: |
| ||||||||||||||||||||
Recovery: |
| ||||||||||||||||||||
Function: | Binds to TGF-beta. Could be involved in capturing and retaining TGF-beta for presentation to the signaling receptors. |
Uniprot: | Q03167 |
Sample Type: | Serum, plasma, tissue homogenates, cell culture supernates and other biological fluids |
Specificity: | Natural and recombinant human Transforming growth factor beta receptor type 3 |
Sub Unit: | Interacts with TCTEX1D4. |
Research Area: | Immunology |
Subcellular Location: | Secreted Secreted Extracellular space Cell membrane Single-pass type I membrane protein Exists both as a membrane-bound form and as soluble form in serum and in the extracellular matrix. |
Storage: | Please see kit components below for exact storage details |
Note: | For research use only |
UniProt Protein Function: | TGFBR3: Binds to TGF-beta. Could be involved in capturing and retaining TGF-beta for presentation to the signaling receptors. Interacts with TCTEX1D4. 2 isoforms of the human protein are produced by alternative splicing. |
UniProt Protein Details: | Protein type:Membrane protein, integral Chromosomal Location of Human Ortholog: 1p33-p32 Cellular Component: proteinaceous extracellular matrix; extracellular space; cell surface; integral to plasma membrane; endoplasmic reticulum; receptor complex; external side of plasma membrane Molecular Function:heparin binding; transforming growth factor beta receptor activity; protein binding; fibroblast growth factor binding; glycosaminoglycan binding; transforming growth factor beta binding; punt binding; activin binding; coreceptor activity; SMAD binding; transforming growth factor beta receptor binding; PDZ domain binding Biological Process: transforming growth factor beta receptor complex assembly; heart morphogenesis; blood vessel development; cell migration; organ regeneration; blastocyst development; positive regulation of transforming growth factor beta receptor signaling pathway; cardiac muscle cell proliferation; negative regulation of cell motility; palate development; liver development; activation of NF-kappaB transcription factor; BMP signaling pathway; transforming growth factor beta receptor signaling pathway; regulation of protein binding; response to hypoxia; epithelial to mesenchymal transition; ventricular cardiac muscle morphogenesis; immune response; cell growth; negative regulation of transforming growth factor beta receptor signaling pathway; response to follicle-stimulating hormone stimulus; negative regulation of epithelial cell proliferation |
NCBI Summary: | This locus encodes the transforming growth factor (TGF)-beta type III receptor. The encoded receptor is a membrane proteoglycan that often functions as a co-receptor with other TGF-beta receptor superfamily members. Ectodomain shedding produces soluble TGFBR3, which may inhibit TGFB signaling. Decreased expression of this receptor has been observed in various cancers. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene.[provided by RefSeq, Sep 2010] |
UniProt Code: | Q03167 |
NCBI GenInfo Identifier: | 307574634 |
NCBI Gene ID: | 7049 |
NCBI Accession: | NP_001182613.1 |
UniProt Secondary Accession: | Q03167,Q5T2T4, Q5U731, Q9UGI2, A0AUW8, A8K5N0, B9EG88 |
UniProt Related Accession: | Q03167 |
Molecular Weight: | 93,499 Da |
NCBI Full Name: | transforming growth factor beta receptor type 3 isoform b |
NCBI Synonym Full Names: | transforming growth factor, beta receptor III |
NCBI Official Symbol: | TGFBR3 |
NCBI Official Synonym Symbols: | BGCAN; betaglycan |
NCBI Protein Information: | transforming growth factor beta receptor type 3; TGFR-3; betaglycan proteoglycan; TGF-beta receptor type 3; TGF-beta receptor type III |
UniProt Protein Name: | Transforming growth factor beta receptor type 3 |
UniProt Synonym Protein Names: | Betaglycan; Transforming growth factor beta receptor III |
UniProt Gene Name: | TGFBR3 |
UniProt Entry Name: | TGBR3_HUMAN |
Component | Quantity (96 Assays) | Storage |
ELISA Microplate (Dismountable) | 8×12 strips | -20°C |
Lyophilized Standard | 2 | -20°C |
Sample Diluent | 20ml | -20°C |
Assay Diluent A | 10mL | -20°C |
Assay Diluent B | 10mL | -20°C |
Detection Reagent A | 120µL | -20°C |
Detection Reagent B | 120µL | -20°C |
Wash Buffer | 30mL | 4°C |
Substrate | 10mL | 4°C |
Stop Solution | 10mL | 4°C |
Plate Sealer | 5 | - |
Other materials and equipment required:
- Microplate reader with 450 nm wavelength filter
- Multichannel Pipette, Pipette, microcentrifuge tubes and disposable pipette tips
- Incubator
- Deionized or distilled water
- Absorbent paper
- Buffer resevoir
*Note: The below protocol is a sample protocol. Protocols are specific to each batch/lot. For the correct instructions please follow the protocol included in your kit.
Allow all reagents to reach room temperature (Please do not dissolve the reagents at 37°C directly). All the reagents should be mixed thoroughly by gently swirling before pipetting. Avoid foaming. Keep appropriate numbers of strips for 1 experiment and remove extra strips from microtiter plate. Removed strips should be resealed and stored at -20°C until the kits expiry date. Prepare all reagents, working standards and samples as directed in the previous sections. Please predict the concentration before assaying. If values for these are not within the range of the standard curve, users must determine the optimal sample dilutions for their experiments. We recommend running all samples in duplicate.
Step | |
1. | Add Sample: Add 100µL of Standard, Blank, or Sample per well. The blank well is added with Sample diluent. Solutions are added to the bottom of micro ELISA plate well, avoid inside wall touching and foaming as possible. Mix it gently. Cover the plate with sealer we provided. Incubate for 120 minutes at 37°C. |
2. | Remove the liquid from each well, don't wash. Add 100µL of Detection Reagent A working solution to each well. Cover with the Plate sealer. Gently tap the plate to ensure thorough mixing. Incubate for 1 hour at 37°C. Note: if Detection Reagent A appears cloudy warm to room temperature until solution is uniform. |
3. | Aspirate each well and wash, repeating the process three times. Wash by filling each well with Wash Buffer (approximately 400µL) (a squirt bottle, multi-channel pipette,manifold dispenser or automated washer are needed). Complete removal of liquid at each step is essential. After the last wash, completely remove remaining Wash Buffer by aspirating or decanting. Invert the plate and pat it against thick clean absorbent paper. |
4. | Add 100µL of Detection Reagent B working solution to each well. Cover with the Plate sealer. Incubate for 60 minutes at 37°C. |
5. | Repeat the wash process for five times as conducted in step 3. |
6. | Add 90µL of Substrate Solution to each well. Cover with a new Plate sealer and incubate for 10-20 minutes at 37°C. Protect the plate from light. The reaction time can be shortened or extended according to the actual color change, but this should not exceed more than 30 minutes. When apparent gradient appears in standard wells, user should terminatethe reaction. |
7. | Add 50µL of Stop Solution to each well. If color change does not appear uniform, gently tap the plate to ensure thorough mixing. |
8. | Determine the optical density (OD value) of each well at once, using a micro-plate reader set to 450 nm. User should open the micro-plate reader in advance, preheat the instrument, and set the testing parameters. |
9. | After experiment, store all reagents according to the specified storage temperature respectively until their expiry. |
When carrying out an ELISA assay it is important to prepare your samples in order to achieve the best possible results. Below we have a list of procedures for the preparation of samples for different sample types.
Sample Type | Protocol |
Serum | If using serum separator tubes, allow samples to clot for 30 minutes at room temperature. Centrifuge for 10 minutes at 1,000x g. Collect the serum fraction and assay promptly or aliquot and store the samples at -80°C. Avoid multiple freeze-thaw cycles. If serum separator tubes are not being used, allow samples to clot overnight at 2-8°C. Centrifuge for 10 minutes at 1,000x g. Remove serum and assay promptly or aliquot and store the samples at -80°C. Avoid multiple freeze-thaw cycles. |
Plasma | Collect plasma using EDTA or heparin as an anticoagulant. Centrifuge samples at 4°C for 15 mins at 1000 × g within 30 mins of collection. Collect the plasma fraction and assay promptly or aliquot and store the samples at -80°C. Avoid multiple freeze-thaw cycles. Note: Over haemolysed samples are not suitable for use with this kit. |
Urine & Cerebrospinal Fluid | Collect the urine (mid-stream) in a sterile container, centrifuge for 20 mins at 2000-3000 rpm. Remove supernatant and assay immediately. If any precipitation is detected, repeat the centrifugation step. A similar protocol can be used for cerebrospinal fluid. |
Cell culture supernatant | Collect the cell culture media by pipette, followed by centrifugation at 4°C for 20 mins at 1500 rpm. Collect the clear supernatant and assay immediately. |
Cell lysates | Solubilize cells in lysis buffer and allow to sit on ice for 30 minutes. Centrifuge tubes at 14,000 x g for 5 minutes to remove insoluble material. Aliquot the supernatant into a new tube and discard the remaining whole cell extract. Quantify total protein concentration using a total protein assay. Assay immediately or aliquot and store at ≤ -20 °C. |
Tissue homogenates | The preparation of tissue homogenates will vary depending upon tissue type. Rinse tissue with 1X PBS to remove excess blood & homogenize in 20ml of 1X PBS (including protease inhibitors) and store overnight at ≤ -20°C. Two freeze-thaw cycles are required to break the cell membranes. To further disrupt the cell membranes you can sonicate the samples. Centrifuge homogenates for 5 mins at 5000xg. Remove the supernatant and assay immediately or aliquot and store at -20°C or -80°C. |
Tissue lysates | Rinse tissue with PBS, cut into 1-2 mm pieces, and homogenize with a tissue homogenizer in PBS. Add an equal volume of RIPA buffer containing protease inhibitors and lyse tissues at room temperature for 30 minutes with gentle agitation. Centrifuge to remove debris. Quantify total protein concentration using a total protein assay. Assay immediately or aliquot and store at ≤ -20 °C. |
Breast Milk | Collect milk samples and centrifuge at 10,000 x g for 60 min at 4°C. Aliquot the supernatant and assay. For long term use, store samples at -80°C. Minimize freeze/thaw cycles. |